Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $349.63M.
ENTERPRISE VALUE (EV)
$349.63M
Cibus, Inc.
Market Cap
$121.37M
Enterprise Value (EV)
$349.63M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Cibus, Inc. (CBUS) | $121.37M | $349.63M |
| enGene Holdings Inc. (ENGN)vs › | $122.26M | $114.50M |
| TuHURA Biosciences, Inc. (HURA)vs › | $120.68M | $120.09M |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $120.28M | $105.15M |
| Genelux Corporation (GNLX)vs › | $118.38M | $111.61M |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.02M | $118.49M |
| Entera Bio Ltd. (ENTX)vs › | $128.49M | $117.61M |
| LENZ Therapeutics, Inc. (LENZ)vs › | $116.95M | $92.87M |
| Coya Therapeutics, Inc. (COYA)vs › | $115.06M | N/A |
| Health Catalyst, Inc. (HCAT)vs › | $131.16M | $240.55M |
Market Cap
$121.37M
Total Debt
$238.18M
Cash
$9.92M
Enterprise Value
$349.63M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
